Background. Schools are purported to be primary venues of influenza transmission and amplification with secondary spread to communities. We assessed K-12 student absenteeism monitoring as a means for early detection of influenza activity in the community.
Methods. We conducted a 3-year, prospective observational study of all-cause (a-TOT), illness-associated (a-I), and influenza-like illness-associated (a-ILI) absenteeism within the Oregon School District, Oregon, WI (OSD: enrollment = 3,900 students). Absenteeism reporting was facilitated by automated processes within OSD's electronic student information system. Students were screened for ILI, and, if eligible, visited at home, where pharyngeal specimens were collected for influenza RT-PCR (IVD CDC Human Influenza Virus RT-PCR Diagnostic Panel) and multipathogen testing (Luminex NxTAG RPP). The study definition of a-ILI was validated for 700 children with acute respiratory infections using binomial logistic regression. Surveillance of medically attended laboratory-confirmed influenza (MAI) occurred in five primary care clinics in and adjoining OSD as part of the Wisconsin Influenza Incidence Surveillance Project using the same laboratory testing. Poisson general additive log linear regression models of daily counts of absenteeism and MAI were compared using correlation analysis.
Results. Influenza A and B were detected in 54 and 51 of the 700 visited students, respectively. Influenza was significantly associated with a-ILI status (OR = 4.74; 95% CI: 2.78-8.18; P < 0.001). Of MAI patients, 371 had influenza A and 143 had influenza B. a-I was significantly correlated with MAI in the community (r = 0.472; P < 0.001) with a 15-day lead time. a-ILI was significantly correlated with MAI in the community (r = 0.480; P < 0.001) with a 1-day lead time. a-TOT performed poorly (r = 0.278; P < 0.001), following MAI by 9 days (Figure 1 ).
Conclusion. Surveillance using cause-specific absenteeism was feasible to implement in OSD and performed well over a 3-year period marked by diverse presentations of seasonal influenza. Monitoring a-I and a-ILI can detect influenza outbreaks in the community, providing early warning in time for community mitigation efforts for seasonal and pandemic influenza.
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No reported disclosures. Background. Influenza illness can range from mild to severe, with serious outcomes occurring in children and the elderly. Flu has been studied extensively in geographies where vaccine is often plentiful. The burden of influenza is not well known in tropical regions where vaccine coverage is scant. Our study examines the impact of introducing flu vaccination on cumulative incidence in a Cameroonian population with <0.2% influenza vaccine utilization Methods. The data consists of 1 year of flu surveillance from patients presenting with influenza-like-illness at clinics in Cameroon. Samples underwent RT-PCR influenza screening. Analysis was performed in Berkeley Madonna. We developed ordinary differential equations (ODE)s under the SEIR compartmental model and calculated R0. We estimated the proportion of cases the clinics observed to make inferences to the catchment population of these health facilities. We developed another set of ODEs to introduce vaccination using a pulse function with a 50% efficacy and 45% vaccination coverage.
Modeling the Impact of Introduction of Influenza Vaccination on ILI Cumulative Case Count in Cameroon
Results. We observed 82.9% reduction in flu cases by introducing vaccination at 45% coverage (US average). Cameroon would likely achieve reduced coverage. Therefore, we examined introducing vaccination with 10% coverage, and observed that flu cases were cut by over one third.
Conclusion. This analysis demonstrates that introducing vaccination in Cameroon clinics would reduce influenza cases substantially even with only a small proportion of the population vaccinated. Flu vaccination campaigns should be strongly considered as they can reduce case count which may reduce the likelihood of transmitting flu to those who are at risk the most severe outcomes.
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Impact of Expanded Influenza

Background.
A severe 2017-2018 influenza season was expected for the United States. We hypothesized that a surge in influenza cases paired with decreased vaccine effectiveness could increase healthcare worker (HCW) absenteeism. Because of a potential public health emergency during the 2017-2018 season, we offered oseltamivir post-exposure prophylaxis (PEP) to exposed HCWs regardless of vaccination status. We describe PEP uptake, cost, and impact on absenteeism at the University of Iowa Hospital and Clinics (UIHC).
Methods. UIHC serves as a referral and safety net health system for Eastern Iowa. Influenza seasons were defined as the period between Week 40 from 1 year to Week 13 of the following year. During the 2016-2017 season, PEP (75 mg/day for 7 days) was offered free of charge to unvaccinated exposed HCWs. Exposure was defined as proximity within 3 ft of a confirmed influenza-infected person for ≥10 minutes without mask protection, or direct contact with respiratory secretions. During the 2017-2018 season, PEP was expanded to all exposed HCWs regardless of vaccination status. We reviewed surveillance, employee health, pharmacy, and human resources records for the 2016-2017 and 2017-2018 seasons. We defined PEP uptake as prescriptions picked up/all referrals and absenteeism rate as sick-leave requests/scheduled hours.
Results. During the 2016-2017 and 2017-2018 seasons, we detected 373 and 427 confirmed influenza cases among patients at UIHC. HCW vaccination rates were similar: 89.7% and 90.9%. PEP was recommended in 49 exposures during 2016-2017 and 280 exposures during 2017-2018. A total of 22 (44.9%) and 133 (47.5%) HCWs picked up oseltamivir from the pharmacy during the 2016-2017 and 2017-2018 seasons. The estimated cost of oseltamivir was $1,791 and $10,828, respectively. Overall, 6,187 sick-leave requests (median = 12 hours, absenteeism rate = 3.2%), and 6,174 sick-leave requests (median = 12 hours, absenteeism rate = 3.4%) were reported during the 2016-2017 and 2017-2018 seasons.
Conclusion. Influenza case counts mildly increased from the 2016-2017 to the 2017-2018 season. Expanding PEP to all exposed HCWs, regardless of vaccination status, had moderate uptake and was costly. Absenteeism rates remained similar during both seasons.
Disclosures. 
Methods. Data collected in the nationwide case-control study was reanalyzed. Confirmed narcolepsy cases (Brighton levels 1-2 for ages 0-15 years and 1-4a for ages at least 16 years) with onset during November 1, 2009-September 30, 2010 were included and ascertained receipt of H1N1 vaccines. We compared incidence of narcolepsy between the H1N1 vaccinated and unvaccinated population and assessed daily cumulative risk throughout the study period, with adjustment for age. We applied population estimates (census data, 2009) and daily doses of H1N1 vaccines administered (Influenza Vaccine Information System) to calculate the number of persons and person-time for each group.
Results. There were 22 narcolepsy cases; five (23%) occurred after H1N1 vaccination. The vaccinated population had higher incidence (1.2 vs. 1.0 per million person-years, P = 0.711) (incidence rate ratio 1.24, 95% confidence interval [CI] 0.40-3.83), and higher cumulative risk (1.1 vs. 0.9 per million persons, P = 0.772) (risk ratio 1.16, 95% CI 0.43-3.14) of narcolepsy (figure). These differences, however, were not significant.
Conclusion. We found comparable average and cumulative risk of narcolepsy between the H1N1 vaccinated and unvaccinated Taiwanese Background. Influenza and bacterial coinfection are associated with increased symptom severity and worse health outcomes. We used data from the population based Influenza Hospitalization Surveillance Network (FluSurv-Net) California site to describe adult influenza hospitalizations with and without bacterial coinfections and evaluate the risk of severe disease.
Bacterial Coinfections Among Adults
Methods. We included data from adults hospitalized with laboratory confirmed influenza during the 2016/2017 influenza season who resided in San Francisco, Alameda or Contra Costa counties and had a bacterial culture performed ≤ 3 days after admission. We excluded records for healthcare facility-associated influenza. Univariate analyses were used to describe demographics, clinical characteristics and outcomes. Multivariate logistic regression was used to evaluate the effect of bacterial coinfection as a risk factor for severe outcome, defined as admission to an intensive care unit (ICU) or death during hospitalization.
Results. Among 2,029 adult influenza hospitalizations, 102 had ≥1 positive bacterial cultures. There were 119 bacterial isolates from blood (58), respiratory sites (60), and joint fluid (1). The most frequent blood isolates were Streptococcus pneumoniae (11), and Staphylococcus aureus (10). The most frequent respiratory isolates were S. aureus (30) and S. pneumoniae (7). Coinfected persons were younger (median age 71 vs. 78), and more likely to have past or current alcohol abuse or immunosuppression. Coinfected patients were more likely to be admitted to an ICU (45% vs. 15%) or die (16.0% vs. 3.6%). The median length of hospital stay was twice as long for coinfected patients (6 days vs. 3). In multivariate analyses, bacterial coinfection (aOR, 4.49; 95% CI, 2.99-6.72), chronic lung disease (aOR, 1.52; 95% CI, 1.18-1.95) and cardiovascular disease (aOR, 1.48; 95% CI, 1.15-1.90) were associated with a severe outcome.
Conclusion. Bacterial coinfection was associated with a four-fold higher risk of ICU admission and death during hospitalization. This study highlights the need for clinicians to maintain a high index of suspicion for the presence of bacterial coinfection among patients with influenza requiring hospitalization.
Disclosures. Background. Information regarding influenza activity can inform clinical and public health activities. However, current surveillance approaches induce a delay in influenza activity reports (typically 1-2 weeks) . Recently, we used data from smartphone connected thermometers to accurately forecast real-time influenza activity at a national level. Because thermometer readings can be geo-located, we used state-level thermometer data to determine whether these data can improve state-level surveillance estimates.
Methods. We used temperature readings collected by the Kinsa smart-thermometer and mobile device app to develop state-level forecasting models to predict real-time influenza activity (1-2 weeks in advance of surveillance reports). We used state-reported influenza-like illness (ILI) to represent state influenza activity for 48 US states with sufficient surveillance data. Counts of temperature readings, fever episodes and reported symptoms were computed by week. We developed autoregressive time-series models and evaluated model performance in an adaptive out-of-sample manner. We compared baseline time-series models containing lagged state-reported ILI activity to models incorporating exogenous thermometer readings.
Results. A total of 10,262,212 temperature readings were recorded from October 30, 2015 to March 29, 2018. In nearly all of the 48 states considered, weekly forecasts of ILI activity improved considerably when thermometer readings were incorporated. On average, state-level forecasting accuracy improved by 23.9% compared with baseline time-series models. In many states, such as PA, New Mexico, MA, Virginia, New York and SC, out-of-sample forecast error was reduced by more than 50% when thermometer data were incorporated. In general, forecasts were most accurate in states with the greatest number of device readings. During the 2017-2018 influenza season, the average improvement in forecast accuracy was 24.4%, and thermometer readings improved forecasting accuracy in 41, out of 48, states.
Conclusion. Data from smart thermometers accurately track real-time influenza activity at a state level. Local surveillance efforts may be improved by incorporating such information. Such data may also be useful for longer-term local forecasts. Methods. Trends and relationships of WNV cases and climatic factors were analyzed among the regions of the United States from 2003 to 2014. Human WNV tabulate data and climatic data were obtained from Centers for Disease Control, and NOAA and Climate Data Guide, respectively. Canonical correspondence analysis (CCA) was performed using variables: (i) neuroinvasive disease cases, non-neuroinvasive disease cases, deaths, presumptiveviremic blood donors, (ii) precipitation, temperature, Palmer Drought Severity Index (PDSI) and population density. The CCA ordination was explained the variability between WNV disease cases andclimatic variables. Biplots were used to visualize the associations between WNV cases and climatic anomalies.
Results. We compared the state wise WNV disease cases in relation to climatic and population density in the United States from 2003 to 2014. A total of 4,064 cases in 2006, 956 cases in 2010 and, 2,141 cases in 2014 were reported in the 32 states of the United States. Colorado state reported the highest WNV cases in 2003 (2,947 cases; 33%), followed by Texas in 2012 (1,868 cases; 35%) and California in 2014 (801 case; 37%). CCA ordination showed distinguishable clustering patterns between south central (Texas, Louisiana, Mississippi, Arkansas, and Oklahoma) and northern Great Plains (North Dakota, South Dakota, and Nebraska) regions (Figure 1 ). High temperature and prolong drought were the most important variable predictor for high WNV outbreak.
